# Sarepta Therapeutics, Inc.: Form 8-K, filed Jun 7, 2024

- Company: [Sarepta Therapeutics, Inc.](/companies/srpt.md) (CIK 873303)
- Form: 8-K
- Filed: 2024-06-07
- Accepted by EDGAR: Jun 7, 2024, 16:45 ET
- Period: 2024-06-06
- Accession: 0001193125-24-157458
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/873303/000119312524157458/d810236d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/873303/000119312524157458/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/873303/000119312524157458/d810236d8k.htm

Filed Jun 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-157458. Last ingested by Listed: Nov 10, 2026, 17:28 ET. No prices; not investment advice.